SUBSCRIBE
SUBSCRIBE

Sarepta Therapeutics, Inc.

NEWS
This Is Why Woodcock OKed Sarepta's DMD Drug
FDA
This Is Why Woodcock OKed Sarepta’s DMD Drug
November 4, 2016
 · 
3 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Genetown
Humana to Cover Sarepta’s Controversial DMD Drug But There’s a Catch
October 27, 2016
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
Sarepta Gets No Love From the FDA’s New Drugs Director
October 20, 2016
 · 
3 min read
BioCapital
SunTrust Managing Director Goes Over Sarepta’ Story
October 18, 2016
 · 
1 min read
Policy
PTC Therapeutics Wants a Slice of Sarepta’s DMD Pie, Says Rejected Drug May Help Some Patients
October 7, 2016
 · 
1 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Business
Sarepta Goes for a New DMD Combo With New $562 Million+ Deal With Summit Therapeutics
October 4, 2016
 · 
2 min read
Policy
After Sarepta’s Win, BioMarin Wants a Piece of the Action Too
September 23, 2016
 · 
1 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Drug Development
Saga Continues for Sarepta as FDA Head Calls for Retraction of ‘Misleading’ 2013 Study
September 23, 2016
 · 
3 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Job Trends
The Power of Three: Sarepta to Open New Plant, Hire Staff and Confirms Kaye as CEO
September 21, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 30, 2020
November 30, 2020
 · 
2 min read
Genetown
Sarepta Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
November 25, 2020
 · 
1 min read
Genetown
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020
November 20, 2020
 · 
3 min read
Business
Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
November 5, 2020
 · 
35 min read
Genetown
Sarepta Therapeutics to Commence Dosing of the Next Study with Commercial Process Material for the SRP-9001 Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy
November 5, 2020
 · 
6 min read
Genetown
Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
November 2, 2020
 · 
1 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 30, 2020
October 30, 2020
 · 
2 min read
Business
Sarepta Therapeutics to Announce Third Quarter 2020 Financial Results and Recent Corporate Developments on November 5, 2020
October 29, 2020
 · 
1 min read
Business
Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics
October 22, 2020
 · 
10 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 30, 2020
September 30, 2020
 · 
2 min read
Load More